News from Conclusio

Latest Articles and News from Conclusio


James Roach, in his NHS role,  looks at the future for biosimilar medicines, surveys a future landscape where medicines management will be performed at ICS level, and suggests that pharma can be a crucial player in NHS transformation

https://wilmingtonhealthcare.com/what-next-for-biosimilars/


James Roach and Johnny Skillicorn-Aston, Conclusio
January 2020

Driving innovation in a modern NHS - What is pharma’s role and what does it mean for patients? Pharmafield

https://pharmafield.co.uk/in_depth/driving-innovation-in-a-modern-nhs/


James Roach and Johnny Skillicorn-Aston, Conclusio 

December 2019

Let’s seize the opportunity to change the dynamic. Pharmacy needs to push the case for a change in the point of patient interaction and so help manage access pressures. Pharmacy Magazine -

 https://www.pharmacymagazine.co.uk/lets-seize-the-opportunity-to-change-the-dynamic


Johnny Skillicorn-Aston, Director of Engagement and communication, Conclusio

October 2019

A recent roundtable event attended by academics, nutrition experts and health and industry leaders brought into sharp focus the issue of malnutrition and its consequences for health and wellbeing. 

https://flickread.com/edition/html/index.php?pdf=5ddbee05a2dd8#15 


From elsewhere - Amanda Barrell writing in PharmaPhorum

A move towards integrated care systems (ICS), complete with new primary care roles, and a greater focus on public health is shaking the healthcare system to its core. But what does this mean for industry?

Mike Proctor, recently retired chief executive of York Teaching Hospital NHS Foundation Trust, quoted in the articles "Iindustry could become a crucial part of this new world – but routes to success vary across the country." 
He advised delegates to adopt a flexible, regional approach, be prepared to move from national to local priorities, and to build relationships with the new decision makers.
“There is a dream of a truly integrated social care, primary care, secondary care and mental health care. We do believe this is the right thing to do but the bottom line is there is no one size to fit all,” he said, adding that the only unifying factor was reducing hospital admissions. Don’t sell boxes, sell solutions. Develop products that keep people out of hospital – that is key. If you can find ways to keep people out of hospital and you can support that in some way, the door is open,”


Events:

Ethical Medicines Industry Group - 11 November 2019

James Roach speaking to EMIG today and says ' 'The time couldn't be better for NHS and industry partnerships; but effective partnerships need co-ownership of the challenge and equity across risks and benefits.'

PHOTO-2019-11-11-12-13-41jpg


HSJ Awards 6 November - 

James Roach part of the judging panel and presenting award 

PHOTO-2019-11-07-10-33-592857jpg


Driving Forward Market Access in the new NHS Environment. Mtech Access.  25th September 2019.   http://www.mtechaccess.co.uk/seminar-new-nhs-environment/#engaging-with-impact 
James Roach presented on Engaging with Impact: Market Access and the new NHS.

Video at   https://www.youtube.com/watch?v=a51I5X2hOtw&t=24s.



HSJ Life Sciences Forum - June 2019

James Roach speaking as a part of the panel

James Roach speaking at the Westminster Health Forum on Biosimilars, 16th July 2019.


Westminster Health forumjpg